Literature DB >> 6268485

Neuroendocrine carcinoma of the cervix: implications for staging and therapy.

R Pazdur, P Bonomi, R Slayton, V E Gould, A Miller, W Jao, T Dolan, G Wilbanks.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 6268485     DOI: 10.1016/0090-8258(81)90103-7

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  6 in total

1.  Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix.

Authors:  W J Tian; M Q Zhang; R H Shui
Journal:  Oncol Lett       Date:  2011-10-12       Impact factor: 2.967

2.  A retrospective clinicopathological analysis of small-cell carcinoma of the uterine cervix.

Authors:  Samina Dongol; Yanhong Tai; Yi Shao; Jie Jiang; Beihua Kong
Journal:  Mol Clin Oncol       Date:  2013-09-25

3.  Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.

Authors:  Ling-Min Liao; Xin Zhang; Yu-Feng Ren; Xiao-Ying Sun; Na Di; Nan Zhou; Rui-Ke Pan; Shu-Hua Ma; Li-Xue Zhou
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

4.  Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.

Authors:  Long Huang; Jia-Xin Lin; Yan-Hong Yu; Mei-Yin Zhang; Hui-Yun Wang; Min Zheng
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

Review 5.  [Neuroendocrine tumors of the cervix: case study and literature review].

Authors:  Kaoutar Rais; Ebo Egyir; Obeid Rockson; Abdelbassir Ramdani; Badr Serji; Tijani El Harroudi
Journal:  Pan Afr Med J       Date:  2019-09-24

6.  Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.

Authors:  Long Huang; Ling-Min Liao; An-Wen Liu; Jian-Bing Wu; Xiao-Ling Cheng; Jia-Xin Lin; Min Zheng
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.